#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Deciphering Normal Blood Gene Expression Variation—The NOWAC Postgenome Study


There is growing evidence that gene expression profiling of peripheral blood cells is a valuable tool for assessing gene signatures related to exposure, drug-response, or disease. However, the true promise of this approach can not be estimated until the scientific community has robust baseline data describing variation in gene expression patterns in normal individuals. Using a large representative sample set of postmenopausal women (N = 286) in the Norwegian Women and Cancer (NOWAC) postgenome study, we investigated variability of whole blood gene expression in the general population. In particular, we examined changes in blood gene expression caused by technical variability, normal inter-individual differences, and exposure variables at proportions and levels relevant to real-life situations. We observe that the overall changes in gene expression are subtle, implying the need for careful analytic approaches of the data. In particular, technical variability may not be ignored and subsequent adjustments must be considered in any analysis. Many new candidate genes were identified that are differentially expressed according to inter-individual (i.e. fasting, BMI) and exposure (i.e. smoking) factors, thus establishing that these effects are mirrored in blood. By focusing on the biological implications instead of directly comparing gene lists from several related studies in the literature, our analytic approach was able to identify significant similarities and effects consistent across these reports. This establishes the feasibility of blood gene expression profiling, if they are predicated upon careful experimental design and analysis in order to minimize confounding signals, artifacts of sample preparation and processing, and inter-individual differences.


Vyšlo v časopise: Deciphering Normal Blood Gene Expression Variation—The NOWAC Postgenome Study. PLoS Genet 6(3): e32767. doi:10.1371/journal.pgen.1000873
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1000873

Souhrn

There is growing evidence that gene expression profiling of peripheral blood cells is a valuable tool for assessing gene signatures related to exposure, drug-response, or disease. However, the true promise of this approach can not be estimated until the scientific community has robust baseline data describing variation in gene expression patterns in normal individuals. Using a large representative sample set of postmenopausal women (N = 286) in the Norwegian Women and Cancer (NOWAC) postgenome study, we investigated variability of whole blood gene expression in the general population. In particular, we examined changes in blood gene expression caused by technical variability, normal inter-individual differences, and exposure variables at proportions and levels relevant to real-life situations. We observe that the overall changes in gene expression are subtle, implying the need for careful analytic approaches of the data. In particular, technical variability may not be ignored and subsequent adjustments must be considered in any analysis. Many new candidate genes were identified that are differentially expressed according to inter-individual (i.e. fasting, BMI) and exposure (i.e. smoking) factors, thus establishing that these effects are mirrored in blood. By focusing on the biological implications instead of directly comparing gene lists from several related studies in the literature, our analytic approach was able to identify significant similarities and effects consistent across these reports. This establishes the feasibility of blood gene expression profiling, if they are predicated upon careful experimental design and analysis in order to minimize confounding signals, artifacts of sample preparation and processing, and inter-individual differences.


Zdroje

1. TwineNC

StoverJA

MarshallB

DukartG

HidalgoM

2003 Disease-associated expression profiles in peripheral blood mononuclear cells from patients with advanced renal cell carcinoma. Cancer Res 63 6069 6075

2. TangY

NeeAC

LuA

RanR

SharpFR

2003 Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 23 310 319

3. GladkevichA

KauffmanHF

KorfJ

2004 Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 28 559 576

4. AchironA

GurevichM

FriedmanN

KaminskiN

MandelM

2004 Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann Neurol 55 410 417

5. SharmaP

SahniNS

TibshiraniR

SkaaneP

UrdalP

2005 Early detection of breast cancer based on gene-expression patterns in peripheral blood cells. Breast Cancer Res 7 R634 R644

6. BurczynskiME

TwineNC

DukartG

MarshallB

HidalgoM

2005 Transcriptional profiles in peripheral blood mononuclear cells prognostic of clinical outcomes in patients with advanced renal cell carcinoma. Clin Cancer Res 11 1181 1189

7. LampeJW

StepaniantsSB

MaoM

RadichJP

DaiH

2004 Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 13 445 453

8. WangZ

NeuburgD

LiC

SuL

KimJY

2005 Global gene expression profiling in whole-blood samples from individuals exposed to metal fumes. Environ Health Perspect 113 233 241

9. AmundsonSA

DoKT

ShahabS

BittnerM

MeltzerP

2000 Identification of potential mRNA biomarkers in peripheral blood lymphocytes for human exposure to ionizing radiation. Radiat Res 154 342 346

10. DumeauxV

JohansenJ

Borresen-DaleAL

LundE

2006 Gene expression profiling of whole-blood samples from women exposed to hormone replacement therapy. Mol Cancer Ther 5 868 876

11. WildCP

2009 Environmental exposure measurement in cancer epidemiology. Mutagenesis 24 117 125

12. DebeyS

SchoenbeckU

HellmichM

GathofBS

PillaiR

2004 Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4 193 207

13. EadyJJ

WortleyGM

WormstoneYM

HughesJC

AstleySB

2005 Variation in gene expression profiles of peripheral blood mononuclear cells from healthy volunteers. Physiol Genomics 22 402 411

14. FeezorRJ

BakerHV

MindrinosM

HaydenD

TannahillCL

2004 Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19 247 254

15. McPhailS

GoralskiTJ

2005 Overcoming challenges of using blood samples with gene expression microarrays to advance patient stratification in clinical trials. Drug Discov Today 10 1485 1487

16. TannerMA

BerkLS

FeltenDL

BlidyAD

BitSL

2002 Substantial changes in gene expression level due to the storage temperature and storage duration of human whole blood. Clin Lab Haematol 24 337 341

17. ThachDC

LinB

WalterE

KruzelockR

RowleyRK

2003 Assessment of two methods for handling blood in collection tubes with RNA stabilizing agent for surveillance of gene expression profiles with high density microarrays. J Immunol Methods 283 269 279

18. WhitneyAR

DiehnM

PopperSJ

AlizadehAA

BoldrickJC

2003 Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100 1896 1901

19. RadichJP

MaoM

StepaniantsS

BieryM

CastleJ

2004 Individual-specific variation of gene expression in peripheral blood leukocytes. Genomics 83 980 988

20. CobbJP

MindrinosMN

Miller-GrazianoC

CalvanoSE

BakerHV

2005 Application of genome-wide expression analysis to human health and disease. Proc Natl Acad Sci U S A 102 4801 4806

21. DumeauxV

Borresen-DaleAL

FrantzenJO

KumleM

KristensenVN

2008 Gene expression analyses in breast cancer epidemiology: the Norwegian Women and Cancer postgenome cohort study. Breast Cancer Res 10 R13

22. LundE

DumeauxV

BraatenT

HjartakerA

EngesetD

2008 Cohort profile: The Norwegian Women and Cancer Study–NOWAC–Kvinner og kreft. Int J Epidemiol 37 36 41

23. DumeauxV

LundE

Borresen-DaleAL

2008 Comparaison of globin RNA processnig methods for genome-wide transcriptome analysis from whole blood. Biomarkers in Medicine 2 11 21

24. LundE

DumeauxV

2008 Systems epidemiology in cancer. Cancer Epidemiol Biomarkers Prev 17 2954 2957

25. MansmannU

MeisterR

2005 Testing differential gene expression in functional groups. Goeman's global test versus an ANCOVA approach. Methods Inf Med 44 449 453

26. GoemanJJ

van de GeerSA

deKF

van HouwelingenHC

2004 A global test for groups of genes: testing association with a clinical outcome. Bioinformatics 20 93 99

27. DennisGJr

ShermanBT

HosackDA

YangJ

GaoW

2003 DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4 3

28. HuttenhowerC

HaleyEM

HibbsMA

DumeauxV

BarrettDR

2009 Exploring the human genome with functional maps. Genome Res 19 1093 1106

29. KanehisaM

GotoS

2000 KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28 27 30

30. ChenLS

StoreyJD

2008 Eigen-R2 for dissecting variation in high-dimensional studies. Bioinformatics 24 2260 2262

31. van LeeuwenDM

vanAE

GottschalkRW

VlietinckR

GielenM

2007 Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs. Carcinogenesis 28 691 697

32. ConnollyPH

CaiozzoVJ

ZaldivarF

NemetD

LarsonJ

2004 Effects of exercise on gene expression in human peripheral blood mononuclear cells. J Appl Physiol 97 1461 1469

33. FrasorJ

StossiF

DanesJM

KommB

LyttleCR

2004 Selective estrogen receptor modulators: discrimination of agonistic versus antagonistic activities by gene expression profiling in breast cancer cells. Cancer Res 64 1522 1533

34. BouwensM

AfmanLA

MullerM

2007 Fasting induces changes in peripheral blood mononuclear cell gene expression profiles related to increases in fatty acid beta-oxidation: functional role of peroxisome proliferator activated receptor alpha in human peripheral blood mononuclear cells. Am J Clin Nutr 86 1515 1523

35. LundE

KumleM

BraatenT

HjartakerA

BakkenK

2003 External validity in a population-based national prospective study–the Norwegian Women and Cancer Study (NOWAC). Cancer Causes Control 14 1001 1008

36. HjartakerA

AndersenLF

LundE

2007 Comparison of diet measures from a food-frequency questionnaire with measures from repeated 24-hour dietary recalls. The Norwegian Women and Cancer Study. Public Health Nutr 1 10

37. ParrCL

VeierodMB

LaakeP

LundE

HjartakerA

2006 Test-retest reproducibility of a food frequency questionnaire (FFQ) and estimated effects on disease risk in the Norwegian Women and Cancer Study (NOWAC). Nutr J 5 4

38. WaasethM

BakkenK

DumeauxV

OlsenKS

RylanderC

2008 Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis. BMC Womens Health 8 1

39. FryeRE

SchwartzBS

DotyRL

1990 Dose-related effects of cigarette smoking on olfactory function. JAMA 263 1233 1236

40. KatotomichelakisM

BalatsourasD

TripsianisG

DavrisS

MaroudiasN

2007 The effect of smoking on the olfactory function. Rhinology 45 273 280

41. SchlagerJJ

PowisG

1990 Cytosolic NAD(P)H:(quinone-acceptor)oxidoreductase in human normal and tumor tissue: effects of cigarette smoking and alcohol. Int J Cancer 45 403 409

42. OroszZ

CsiszarA

LabinskyyN

SmithK

KaminskiPM

2007 Cigarette smoke-induced proinflammatory alterations in the endothelial phenotype: role of NAD(P)H oxidase activation. Am J Physiol Heart Circ Physiol 292 H130 H139

43. JensenEJ

PedersenB

FrederiksenR

DahlR

1998 Prospective study on the effect of smoking and nicotine substitution on leucocyte blood counts and relation between blood leucocytes and lung function. Thorax 53 784 789

44. SchwartzJ

WeissST

1994 Cigarette smoking and peripheral blood leukocyte differentials. Ann Epidemiol 4 236 242

45. BadawiAF

HabibSL

MohammedMA

AbadiAA

MichaelMS

2002 Influence of cigarette smoking on prostaglandin synthesis and cyclooxygenase-2 gene expression in human urinary bladder cancer. Cancer Invest 20 651 656

46. BeloquiO

ParamoJA

OrbeJ

BenitoA

ColinaI

2005 Monocyte cyclooxygenase-2 overactivity: a new marker of subclinical atherosclerosis in asymptomatic subjects with cardiovascular risk factors? Eur Heart J 26 153 158

47. KapoorD

JonesTH

2005 Smoking and hormones in health and endocrine disorders. Eur J Endocrinol 152 491 499

48. KvaavikE

MeyerHE

TverdalA

2004 Food habits, physical activity and body mass index in relation to smoking status in 40–42 year old Norwegian women and men. Prev Med 38 1 5

49. TanakaS

InoueS

IsodaF

WasedaM

IshiharaM

1993 Impaired immunity in obesity: suppressed but reversible lymphocyte responsiveness. Int J Obes Relat Metab Disord 17 631 636

50. NiemanDC

HensonDA

Nehlsen-CannarellaSL

EkkensM

UtterAC

1999 Influence of obesity on immune function. J Am Diet Assoc 99 294 299

51. ZimmetP

TurnerR

McCartyD

RowleyM

MackayI

1999 Crucial points at diagnosis. Type 2 diabetes or slow type 1 diabetes. Diabetes Care 22 Suppl 2 B59 B64

52. SyedMA

Barinas-MitchellE

PietropaoloSL

ZhangYJ

HendersonTS

2002 Is type 2 diabetes a chronic inflammatory/autoimmune disease? Diabetes Nutr Metab 15 68 83

53. SchmidtMI

DuncanBB

SharrettAR

LindbergG

SavagePJ

1999 Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study. Lancet 353 1649 1652

54. PietropaoloM

Barinas-MitchellE

PietropaoloSL

KullerLH

TruccoM

2000 Evidence of islet cell autoimmunity in elderly patients with type 2 diabetes. Diabetes 49 32 38

55. LewisMR

TracyRP

2002 The role of the immune system in the insulin resistance syndrome. Curr Diab Rep 2 96 99

56. DhalluinC

CarlsonJE

ZengL

HeC

AggarwalAK

1999 Structure and ligand of a histone acetyltransferase bromodomain. Nature 399 491 496

57. ZengL

ZhouMM

2002 Bromodomain: an acetyl-lysine binding domain. FEBS Lett 513 124 128

58. KlugA

1999 Zinc finger peptides for the regulation of gene expression. J Mol Biol 293 215 218

59. GarfinkelMD

RudenDM

2004 Chromatin effects in nutrition, cancer, and obesity. Nutrition 20 56 62

60. LiL

YingL

NaesensM

XiaoW

SigdelT

2008 Interference of globin genes with biomarker discovery for allograft rejection in peripheral blood samples. Physiol Genomics 32 190 197

61. RainenL

OelmuellerU

JurgensenS

WyrichR

BallasC

2002 Stabilization of mRNA expression in whole blood samples. Clin Chem 48 1883 1890

62. DebeyS

ZanderT

BrorsB

PopovA

EilsR

2006 A highly standardized, robust, and cost-effective method for genome-wide transcriptome analysis of peripheral blood applicable to large-scale clinical trials. Genomics 87 653 664

63. LiuJ

WalterE

StengerD

ThachD

2006 Effects of globin mRNA reduction methods on gene expression profiles from whole blood. J Mol Diagn 8 551 558

64. LeekJT

StoreyJD

2007 Capturing heterogeneity in gene expression studies by surrogate variable analysis. PLoS Genet 3 e161 doi:10.1371/journal.pgen.0030161

65. LeekJT

StoreyJD

2008 A general framework for multiple testing dependence. Proc Natl Acad Sci U S A 105 18718 18723

66. TroyanskayaO

CantorM

SherlockG

BrownP

HastieT

2001 Missing value estimation methods for DNA microarrays. Bioinformatics 17 520 525

67. BenjaminiY

HochbergY

1995 Controlling the false discovery rate: a practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 57 289 300

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2010 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Získaná hemofilie - Povědomí o nemoci a její diagnostika
nový kurz

Eozinofilní granulomatóza s polyangiitidou
Autori: doc. MUDr. Martina Doubková, Ph.D.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#